4
Jun

Immunotherapy drug effective for metastatic triple negative breast cancer

Via Top Health News -- ScienceDaily

The immunotherapy drug, Pembrolizumab, is effective in shrinking tumors among metastatic triple negative breast cancer patients as found in a clinical trial.

View original post here:

%d bloggers like this: